RA Capital Healthcare Fund LP's Form 4 filing
Vor Biopharma Inc. (VOR) · filed Oct 22, 2025
- Accession no.
- 0001231919-25-000342
- Filed
- Oct 22, 2025, 7:48 PM ET
- Trade date
- Oct 20-21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.43M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Director, 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | Director, 10% Owner |
| Kolchinsky PeterCIK 0001384859 | Director, 10% Owner |
| Shah Rajeev M.CIK 0001619841 | Director, 10% Owner |
| RA Capital Nexus Fund, L.P.CIK 0001780117 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | Common Stock | SSaleDisposed | −70,366 | $29.63 | −$2,084,944.58 | 1,432,806 | Indirect | |
| Oct 20, 2025 | Common Stock | SSaleDisposed | −13,817 | $29.63 | −$409,397.71 | 1,287 | Indirect | |
| Oct 20, 2025 | Common Stock | SSaleDisposed | −6,553 | $30.12 | −$197,376.36 | 1,426,253 | Indirect | |
| Oct 20, 2025 | Common Stock | SSaleDisposed | −1,287 | $30.12 | −$38,764.44 | 0 | Indirect | |
| Oct 21, 2025 | Common Stock | SSaleDisposed | −25,027 | $28.11 | −$703,508.97 | 1,401,226 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.